The 'immunologic advantage' of HIV-exposed seronegative individuals

AIDS. 2009 Jan 14;23(2):161-75. doi: 10.1097/QAD.0b013e3283196a80.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Disease Susceptibility
  • HIV Antibodies / biosynthesis
  • HIV Seronegativity / genetics
  • HIV Seronegativity / immunology*
  • Humans
  • Immunity, Cellular
  • Immunity, Innate
  • Terminology as Topic

Substances

  • HIV Antibodies